Enterprise Therapeutics vs Saluda Medical
Side-by-side comparison of AI visibility scores, market position, and capabilities
Ion Channel Drug Discovery for Respiratory Disease
Enterprise Therapeutics is a UK-based drug discovery biotech targeting ion channels and mucus biology to treat cystic fibrosis, COPD, and non-CF bronchiectasis; raised ~£50M+ from Syncona and other VCs;
About
Enterprise Therapeutics is a British biotechnology company founded in 2012 and headquartered in Brighton, United Kingdom, focused on discovering and developing small-molecule drugs that target ion channels and mucus secretion biology in the airways. The company's scientific foundation draws on the biology of chloride and calcium-activated channels — particularly the TMEM16A chloride channel — which regulate mucus production and hydration in the lungs. Dysfunctional mucus clearance is a common pathological feature of cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and non-CF bronchiectasis, conditions that collectively affect tens of millions of patients globally. By modulating these channels with small molecules, Enterprise Therapeutics aims to develop treatments that restore airway surface liquid and improve mucociliary clearance independent of the genetic mutation driving the disease.
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
About
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
AI Visibility Head-to-Head
Key Details
Also Compare
Enterprise Therapeutics vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.